The Vanguard Group 13D and 13G filings for Castle Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-30 9:33 pm Purchase |
2024-12-31 | 13G | Castle Biosciences, Inc. CSTL |
The Vanguard Group | 1,832,535 6.540% |
371,054 (+25.39%) |
Filing |
| 2024-02-13 5:01 pm Purchase |
2023-12-29 | 13G | Castle Biosciences, Inc. CSTL |
The Vanguard Group | 1,461,481 5.430% |
68,757 (+4.94%) |
Filing |
| 2023-02-09 11:12 am Purchase |
2022-12-30 | 13G | Castle Biosciences, Inc. CSTL |
The Vanguard Group | 1,392,724 5.290% |
1,392,724 (New Position) |
Filing |